WNT2 / Protein Wnt-2 · Western blot design guide

Design a Western Blot for WNT2

Real validated WNT2 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-WNT2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for WNT2: expected band ~40.4 kDa, hero antibody M03226, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable WNT2 Western blot protocol sheet — expected band ~40.4 kDa, antibody M03226, controls and PMC citations. Open the full WNT2 WB guide →

WNT2 Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~40.4 kDa
Gel 12–15% (standard starting point)
Negative control ⓘ Suggested KO / knockdown lysate
Important caveats
Reasons your observed band may differ from the expected size.
PTM Glycosylated + Cleaved
Caveat Modification-state controls
Gene-set association MSigDB Hallmark membership
Isoform 1 isoform(s)
Section 1

Real Curated WNT2 Western Blot Protocols

The M03226 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysate(1) Jurkat cell lysate; (2) SKBR-3 cell lysate (catalog M03226)
Gel %12–15% (standard starting point)
Load20–30 µg total protein per lane; optimize for abundance (standard starting point)
TransferStandard semi-dry transfer; verify efficiency (standard starting point)
Membrane0.45 µm PVDF (standard starting point)
Blocking5% milk or 5% BSA in TBST (standard starting point)
Primary antibodyM03226; use the WB datasheet starting dilution (standard starting point)
Primary incubationOvernight at 4 °C (standard starting point)
Secondary antibodySpecies-matched HRP conjugate at validated dilution (standard starting point)
Secondary incubation1 h at room temperature (standard starting point)
Wash3 × 5 min in TBST (standard starting point)
DetectionECL; bracket exposures to avoid saturation (standard starting point)
Section 2

What Is the Expected WNT2 Western Blot Band Size?

Full-length WNT2 is predicted at 40.4 kDa; signal-peptide cleavage and Asn295 glycosylation could affect migration, but no empirical band size is supplied.

What am I looking at on my blot?
Band near 40.4 kDaConsistent with the predicted full-length WNT2 mass; identity needs confirmation
Band below 40.4 kDaCould reflect removal of the 1..25 signal peptide
Band above 40.4 kDaN-linked glycosylation at Asn295 is a possible contributor, but a shift is unproven
Little or no band in whole-cell lysateWNT2 is secreted into the extracellular space and matrix
💡Expected WNT2 appearanceUniProt predicts 40.4 kDa for full-length WNT2, but no empirical band size is supplied; signal-peptide cleavage and Asn295 glycosylation could affect migration, so confirm band identity with controls.
How each factor affects band size
UniProt full-length predicted massProvides a 40.4 kDa reference, not a measured band position
Signal peptide at residues 1..25Contributes to precursor mass before processing
Signal-peptide cleavageProduces a smaller mature chain than the precursor; migration is not supplied
N-linked glycosylation at Asn295May alter apparent size; the magnitude of any shift is unknown
Why is my band missing or off?
SituationLikely causeNext action
No band in lysateWNT2 is secreted and extracellularCheck conditioned medium or an extracellular fraction alongside a positive control
Band higher than expectedAsn295 glycosylation is a possible contributor, but the cause is unconfirmedCompare treated and untreated samples with a band-identity control
Band lower than expectedRemoval of the 1..25 signal peptide is possibleConfirm identity with an independent antibody or WNT2 depletion
Broad smear instead of sharp bandThe supplied features do not establish a cause; variable Asn295 glycosylation is possibleCompare glycosidase-treated and untreated samples and confirm WNT2 identity
Multiple bandsProcessing or Asn295 glycosylation could contribute, but distinct bands are not establishedUse WNT2 depletion and compare treated with untreated samples

Sample controls for WNT2 Western blot

🧪For positive controls for WNT2 in Western blot, you can use a WNT2-expressing sample confirmed experimentally, since no HPA positive sample is supplied.
Positive control: No high/medium HPA tissue identified
Negative control: Suggested KO / knockdown lysate
Loading controls: Run GAPDH, β-actin, and a total-protein stain alongside the samples.
⚠️Feasibility: WNT2 is secreted, so consider conditioned medium if whole-cell lysate gives little signal.

HPA tissue expression evidence for WNT2

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
No high/medium HPA tissues identified in the supplied evidence.

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
No lower-expression tissue rows available in the supplied evidence.
Section 3

Advanced WNT2 Western Blot Tips

Deeper troubleshooting and optimisation questions for WNT2, answered from its protein features.

Could signal peptide processing affect the expected WNT2 band?
Band shift · WNT2 has a signal peptide at residues 1–25. The 40.4 kDa prediction is for the full-length sequence, so account for the signal peptide when comparing it with a processed protein. The supplied features do not give an observed band mass.
Should I expect distinct WNT2 isoform bands?
Isoforms · The supplied UniProt record lists one isoform and no alternative sequence. It therefore provides no basis for assigning multiple bands to annotated WNT2 isoforms. Investigate unexpected bands without assuming an isoform identity.
Which WNT2 glycosylation site should I consider?
PTM · UniProt lists one N-linked glycosylation site at Asn295. This coordinate refers to the supplied 360-residue sequence; antibody or paper numbering may use a different convention. The annotation alone does not show whether glycosylation changes the observed band.
Does this guide establish induction of WNT2?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
How should transfer be checked for WNT2?
Transfer · Standard workflow guidance: verify transfer efficiency for the intended target size before interpreting a weak signal. Use total-protein assessment and optimize transfer for the membrane, gel and apparatus; the labelled catalog values take precedence.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the M03226 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How should WNT2 be quantified?
Quantitation · Standard workflow guidance: quantify only a validated target band within the linear exposure range. Use consistent sample preparation and loading, retain biological replicates, and avoid interpreting saturation or loading differences as regulation.
Why might WNT2 migrate differently from its predicted 40.4 kDa?
Interpretation · 40.4 kDa is the predicted mass for the full-length sequence. WNT2 has a signal peptide at residues 1–25 and one annotated N-linked glycosylation site at Asn295. These features are relevant when assessing apparent mass, but the supplied features do not establish a visible shift or an expected band position.

WNT2 is annotated as secreted and located in the extracellular space and extracellular matrix. Consider those compartments when selecting and comparing samples; a cell-only sample may not represent all annotated WNT2 locations.

UniProt lists 11 disulfide bonds. Record whether samples were analyzed under reducing conditions when comparing bands, since disulfide status can matter for protein structure. The annotation does not predict a particular mobility change.

Use the same sample compartment and preparation across comparisons. WNT2 is annotated in the extracellular space and extracellular matrix, so differences in what was collected could affect measured signal independently of abundance in another compartment.

Compare its position with the full-length 40.4 kDa prediction while considering the 1–25 signal peptide and N-linked site at Asn295. Check the sampled compartment and reducing conditions. These annotations offer possibilities to assess, but none identifies an unexpected band by itself.
Boster reagents

WNT2 Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot analysis of WNT2 expression in (1) Jurkat cell lysate; (2) SKBR-3 cell lysate.
Anti-WNT2 Rabbit Monoclonal Antibody
Cat # M03226
Real WB data Western blot analysis of WNT2 using anti-WNT2 antibody (PB9461). Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. Lane 1: COLO320 Whole Cell Lysate at 40ug, Lane 2: MCF-7 Whole Cell Lysate at 40ug, Lane 3: HELA Whole Cell Lysate at 40ug. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-WNT2 antigen affinity purified polyclonal antibody (Catalog # PB9461) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for WNT2 at approximately 40 kDa. The expected band size for WNT2 is at 40 kDa.
Anti-Wnt2 Antibody Picoband®
Cat # PB9461

Two the supplier anti-WNT2 antibodies have Western blot images. M03226 is shown with Jurkat and SKBR-3 cell lysates; PB9461 is shown with COLO320, MCF-7, and HeLa whole-cell lysates, with a reported band near 40 kDa. No publication evidence is supplied.

Which to pick: Choose M03226 for its listed human, mouse, and rat reactivity, or PB9461 for listed human reactivity and a detailed Western blot protocol. Both have blot images; the captions document the named cell lysates, not testing across every listed species.

Source: BosterBio WNT2 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.